Laurus Investment Counsel Inc. - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 236 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2019. The put-call ratio across all filers is 4.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Laurus Investment Counsel Inc. ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2021$6,990,000
-35.3%
75,234
-37.6%
2.69%
-35.9%
Q4 2020$10,797,000
-12.9%
120,504
+0.4%
4.20%
-31.1%
Q3 2020$12,399,000
-3.4%
119,994
-26.1%
6.09%
-11.4%
Q2 2020$12,840,000
+199.2%
162,369
+118.9%
6.88%
+121.9%
Q1 2020$4,291,000
+201.5%
74,169
+181.2%
3.10%
+285.6%
Q4 2019$1,423,000
+3.2%
26,3790.0%0.80%
-14.1%
Q3 2019$1,379,00026,3790.94%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders